Health TrialsbyHealthPanel

Sexual Health Advocacy for Guys - a Text Messaging-based HIV Prevention Program for Guys Who Are Into Guys

ConditionHIV Infections
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age13-22
SponsorCenter for Innovative Public Health Research

About this trial

SHAG is a text messaging-based HIV prevention program designed for cisgender sexual minority boys and men 13-20 years of age across the United States. Investigators will test it against a control group that receives messages about healthy lifestyle.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

have been assigned male sex at birth and currently have a cisgender identity;

be aged 13-22 years old;

have had anal sex in the past 12 months;

be English-speaking;

Disqualifiers

Being HIV positive

Trial design

Design model

Parallel

Treatments tested in this trial

  • Sexual health advocacy for guys

    Behavioral

    5 month HIV prevention program delivered via text messaging

  • Healthy lifestyle control

    Behavioral

    5 month control group program delivered via text messaging

Treatment groups

5,000 Participants
are divided into 2 treatment groups
Group A: SHAG (Sexual Health Advocacy for Guys)Experimental treatment 1 intervention
Group B: Attention-matched controlPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

HIV Incidence

HIV Incidence determined by home testing kit

Time frame
12-months post-intervention and immediately post-intervention

Secondary outcomes

1

Self-reported HIV incidence

Self-reported HIV Status

Time frame
Post-Intervention, 3-months post, 6-months post, 9-months post, 12-month post
2

Proportion of Participants Testing for an STI

This outcome will be measured as a cumulative indicator of whether the individual has tested for an STI

Time frame
12-month post intervention and immediately post-intervention
3

Proportion of Participants having used PrEP/PEP

This outcome will be measured as a cumulative indicator of whether the individual has used pre-exposure or post-exposure prophylaxis for HIV

Time frame
12-month post-Intervention and immediately post-intervention

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Center for Innovative Public Health Research

Lead sponsor

Source ClinicalTrials.gov
Apply now